We are excited to be a part of this life sciences Industry

We are excited to be a part of this life sciences Industry

- Dr Manbeena Chawla

Merck has opened its first M Lab Collaboration Center in Bangalore which will help biopharmaceutical firms in development and production of molecules at a lab scale. In an interaction with BioSpectrum, Peter Salazar, Head, Process solutions India, Merck, shares his views on the potentiality of such M Lab Centers towards large-scale manufacturing of drugs in the market and much more.

What is the key prospective behind setting up M Lab Collaboration Centers, especially with one coming up in Bangalore?

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck generated sales of €15.0 billion in 66 countries. Founded in 1668, Merck is the world’s oldest pharmaceutical and chemical company.

Our new M Lab is at our site in Peenya at Bangalore, where we had a small laboratory earlier for customer support. It’s now expanded manifolds to bring it in line with the international standards. M Lab is essentially a customer support laboratory where we bring in customers in order to train them on latest technologies in biopharma manufacturing. Our scientists at M Lab have previously worked in these industries and have an understanding of the challenges faced by the industry. The M Lab is an offering of the Life Science business to the industry we support. The training is not charged and our commitment to our customers is a long term association for sustainable growth.